At the single-cell level, ELOVL2 was expressed in tumor cells, cancer associated fibroblasts (CAFs) and smooth muscle cells (SMCs), while PLCG1 was presented in CD4+ and CD8+ T cells, as expected (Figure 6E; Supplementary Figure 7C). Here, PLCG1 is linked to neoplasm.